These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10926322)

  • 1. Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in type 2 diabetes.
    Niskanen L; Voutilainen-Kaunisto R; Teräsvirta M; Karvonen MK; Valve R; Pesonen U; Laakso M; Uusitupa MI; Koulu M
    Exp Clin Endocrinol Diabetes; 2000; 108(3):235-6. PubMed ID: 10926322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects.
    Niskanen L; Karvonen MK; Valve R; Koulu M; Pesonen U; Mercuri M; Rauramaa R; Töyry J; Laakso M; Uusitupa MI
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2266-9. PubMed ID: 10852461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients.
    Pettersson-Fernholm K; Karvonen MK; Kallio J; Forsblom CM; Koulu M; Pesonen U; Fagerudd JA; Groop PH;
    Diabetes Care; 2004 Feb; 27(2):503-9. PubMed ID: 14747236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD.
    Salminen M; Lehtimäki T; Fan YM; Vahlberg T; Kivelä SL
    Public Health Nutr; 2008 Nov; 11(11):1156-62. PubMed ID: 18279562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
    Heikkinen AM; Niskanen LK; Salmi JA; Koulu M; Pesonen U; Uusitupa MI; Komulainen MH; Tuppurainen MT; Kröger H; Jurvelin J; Saarikoski S
    Bone; 2004 Sep; 35(3):589-94. PubMed ID: 15336593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene is not associated with restenosis after coronary stenting.
    Pesonen U; Koch W; Schömig A; Kastrati A
    J Endovasc Ther; 2003 Jun; 10(3):566-72. PubMed ID: 12932169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects.
    Ukkola O; Kesäniemi YA
    Eur J Clin Nutr; 2007 Sep; 61(9):1102-5. PubMed ID: 17268419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Leu7Pro polymorphism of preproNPY on diurnal NPY and hormone secretion in type 2 diabetes.
    Jaakkola U; Koulu M; Karvonen MK; Seppälä H; Pesonen U; Vahlberg T; Kallio J
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):281-6. PubMed ID: 17516289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy.
    Jaakkola U; Pesonen U; Vainio-Jylhä E; Koulu M; Pöllönen M; Kallio J
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):147-52. PubMed ID: 16705546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory effects of blood leukocytes: association with vascular function in neuropeptide Y proline 7-genotyped type 2 diabetes patients.
    Kakko T; Jaakkola U; Raitakari OT; Kallio J
    Diab Vasc Dis Res; 2011 Jul; 8(3):221-8. PubMed ID: 21746772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men.
    Karvonen MK; Valkonen VP; Lakka TA; Salonen R; Koulu M; Pesonen U; Tuomainen TP; Kauhanen J; Nyyssönen K; Lakka HM; Uusitupa MI; Salonen JT
    Atherosclerosis; 2001 Nov; 159(1):145-51. PubMed ID: 11689216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes.
    Jaakkola U; Kakko T; Seppälä H; Vainio-Jylhä E; Vahlberg T; Raitakari OT; Kallio J
    Microvasc Res; 2010 Dec; 80(3):433-9. PubMed ID: 20691708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: the Helsinki Sudden Death Study.
    Ilveskoski E; Viiri LE; Mikkelsson J; Pörsti I; Lehtimäki T; Karhunen PJ
    Atherosclerosis; 2008 Aug; 199(2):445-50. PubMed ID: 18054939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced exercise-induced GH secretion in subjects with Pro7 substitution in the prepro-NPY.
    Kallio J; Pesonen U; Karvonen MK; Kojima M; Hosoda H; Kangawa K; Koulu M
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5348-52. PubMed ID: 11701704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease.
    Erkkilä AT; Lindi V; Lehto S; Laakso M; Uusitupa MI
    Mol Genet Metab; 2002 Mar; 75(3):260-4. PubMed ID: 11914038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Leu7Pro polymorphism of preproNPY is associated with decreased insulin secretion, delayed ghrelin suppression, and increased cardiovascular responsiveness to norepinephrine during oral glucose tolerance test.
    Jaakkola U; Kuusela T; Jartti T; Pesonen U; Koulu M; Vahlberg T; Kallio J
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3646-52. PubMed ID: 15797951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced endothelium-dependent vasodilation in subjects with Proline7 substitution in the signal peptide of neuropeptide Y.
    Järvisalo MJ; Jartti L; Karvonen MK; Pesonen U; Koulu M; Marniemi J; Hammar N; Kaprio J; Paakkunainen U; Simell O; Raitakari OT; Rönnemaa T
    Atherosclerosis; 2003 Apr; 167(2):319-26. PubMed ID: 12818415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.
    Nordman S; Ding B; Ostenson CG; Kärvestedt L; Brismar K; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):282-7. PubMed ID: 15926114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucine 7-proline 7 polymorphism in the signal peptide of neuropeptide Y is not a risk factor for exudative age-related macular degeneration.
    Kaarniranta K; Holopainen JM; Karvonen MK; Koulu M; Kallio J; Pesonen U; Teräsvirta M; Uusitalo H; Immonen I
    Acta Ophthalmol Scand; 2007 Mar; 85(2):188-91. PubMed ID: 17305733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization.
    Koulu M; Movafagh S; Tuohimaa J; Jaakkola U; Kallio J; Pesonen U; Geng Y; Karvonen MK; Vainio-Jylhä E; Pöllönen M; Kaipio-Salmi K; Seppälä H; Lee EW; Higgins RD; Zukowska Z
    Ann Med; 2004; 36(3):232-40. PubMed ID: 15181979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.